Elsevier today announced that ClinicalPath, its oncology decision support solution, has been designated a Recognized Quality ...
Elsevier announced that it has completed the acquisition of Mytonomy, a leader in video-based patient engagement solutions ...
Elsevier, publisher of science journals and clinical decision-support tools, is rolling out an AI-powered research tool it says is built to transform how researchers work. LeapSpace is an AI-assisted ...
Elsevier Health has launched an generative AI-driven version of its flagship clinical decision support tool, ClinicalKey, in partnership with AI company OpenEvidence. The latest add-on module offers ...
It started earlier this month, when Elsevier sent open access forum Academia.edu 2,800 takedown notices for articles it owns the copyright to within a couple of weeks. Academia.edu is a ...
Elsevier this week began revoking the University of California system’s journal access -- more than six months after the two parties failed to reach agreement on a new bundled journal subscription ...
After a year of talks, Dutch publishing giant Elsevier has struck a deal with a group of Norwegian universities that will allow academics to publish the vast majority of their work under open-access ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In 1995, Forbes, the business magazine, made a prediction: Elsevier, the largest publisher of scientific ...
Boiled down to dollars and cents, the battle between the University of California, the nation’s premier producer of academic research, and Reed Elsevier, the world’s leading publisher of academic ...
Designation reflects ClinicalPath's alignment with ASCO certified standardsNEW YORK, May 6, 2026 /PRNewswire/ -- Elsevier today announced that ClinicalPath, its oncology decision support solution ...
Acquisition combines Elsevier's trusted clinical content and broad healthcare offerings with Mytonomy's cloud platform and integrated patient engagement solutionsNEW YORK, May 5, 2026 /PRNewswire/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results